These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26496016)

  • 21. Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.
    Helmreich I; Wagner S; König J; Kohnen R; Szegedi A; Hiemke C; Tadić A
    J Affect Disord; 2015 Apr; 175():199-208. PubMed ID: 25638793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial.
    Voineskos AN; Mulsant BH; Dickie EW; Neufeld NH; Rothschild AJ; Whyte EM; Meyers BS; Alexopoulos GS; Hoptman MJ; Lerch JP; Flint AJ
    JAMA Psychiatry; 2020 Jul; 77(7):674-683. PubMed ID: 32101271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is combination olanzapine and antidepressant medication associated with a more rapid response trajectory than antidepressant alone?
    Parker G; Brotchie H; Parker K
    Am J Psychiatry; 2005 Apr; 162(4):796-8. PubMed ID: 15800157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial.
    Flint AJ; Iaboni A; Mulsant BH; Rothschild AJ; Whyte EM; Meyers BS;
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):332-6. PubMed ID: 23642462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The empirical redefinition of the psychometric criteria for remission in bipolar disorder.
    Berk M; Ng F; Wang WV; Calabrese JR; Mitchell PB; Malhi GS; Tohen M
    J Affect Disord; 2008 Feb; 106(1-2):153-8. PubMed ID: 17655936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and psychometric validation of the psychotic depression assessment scale.
    Østergaard SD; Pedersen CH; Uggerby P; Munk-Jørgensen P; Rothschild AJ; Larsen JI; Gøtzsche C; Søndergaard MG; Bille AG; Bolwig TG; Larsen JK; Bech P
    J Affect Disord; 2015 Mar; 173():261-8. PubMed ID: 25462426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy].
    Schmitt A; Braus DF
    Dtsch Med Wochenschr; 2000 Dec; 125(50):1526-9. PubMed ID: 11190762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the semi-structured Psychotic Depression Assessment Scale (PDAS) interview.
    Köse Çinar R; Østergaard SD
    Acta Neuropsychiatr; 2018 Jun; 30(3):175-180. PubMed ID: 28535843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.
    Blumberger DM; Mulsant BH; Kanellopoulos D; Whyte EM; Rothschild AJ; Flint AJ; Meyers BS
    J Clin Psychopharmacol; 2013 Jun; 33(3):391-7. PubMed ID: 23609383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD.
    Davies SJ; Mulsant BH; Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Kirshner MM; Sorisio D; Pollock BG; Bies RR
    Clin Pharmacokinet; 2015 Nov; 54(11):1161-8. PubMed ID: 25971243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rating scales measuring the severity of psychotic depression.
    Østergaard SD; Rothschild AJ; Flint AJ; Mulsant BH; Whyte EM; Leadholm AK; Bech P; Meyers BS
    Acta Psychiatr Scand; 2015 Nov; 132(5):335-44. PubMed ID: 26016647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.
    Nelson JC; Zhang Q; Deberdt W; Marangell LB; Karamustafalioglu O; Lipkovich IA
    Curr Med Res Opin; 2012 Mar; 28(3):325-34. PubMed ID: 22292447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression.
    Victoria LW; Whyte EM; Butters MA; Meyers BS; Alexopoulos GS; Mulsant BH; Rothschild AJ; Banerjee S; Flint AJ
    Am J Geriatr Psychiatry; 2017 Jun; 25(6):672-679. PubMed ID: 28285771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
    Tadić A; Helmreich I; Mergl R; Hautzinger M; Kohnen R; Henkel V; Hegerl U
    J Affect Disord; 2010 Jan; 120(1-3):86-93. PubMed ID: 19428118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired insight into delusions predicts treatment outcome during a randomized controlled trial for Psychotic Depression (STOP-PD study).
    Gerretsen P; Flint AJ; Whyte EM; Rothschild AJ; Meyers BS; Mulsant BH
    J Clin Psychiatry; 2015 Apr; 76(4):427-33. PubMed ID: 25919834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.
    Andreescu C; Mulsant BH; Peasley-Miklus C; Rothschild AJ; Flint AJ; Heo M; Caswell M; Whyte EM; Meyers BS;
    J Clin Psychiatry; 2007 Feb; 68(2):194-200. PubMed ID: 17335316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial.
    Flint AJ; Bingham KS; Alexopoulos GS; Marino P; Mulsant BH; Neufeld NH; Rothschild AJ; Voineskos AN; Whyte EM; Meyers BS;
    J Psychiatr Res; 2023 Jan; 157():285-290. PubMed ID: 36535116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Validity of the Different Versions of the Hamilton Depression Scale in Separating Remission Rates of Placebo and Antidepressants in Clinical Trials of Major Depression.
    Kyle PR; Lemming OM; Timmerby N; Søndergaard S; Andreasson K; Bech P
    J Clin Psychopharmacol; 2016 Oct; 36(5):453-6. PubMed ID: 27525966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode.
    Hung CI; Liu CY; Wang SJ; Yao YC; Yang CH
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):33-40. PubMed ID: 22122659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.